It’s official. Europe’s first ever myasthenia gravis (MG) awareness day

Friday 2^nd June 2023

What’s Trending?

Testimonials

Hear the lived experiences of MG experts from across Europe.

Myth vs reality

Find out the facts and common misconceptions around MG.

Candid Camera

See the invisible symptoms of MG being made visible, to increase public awareness.

Together, we can make it happen

This is a day to celebrate how far we’ve come in our understanding of the burden of MG. But also, a day to acknowledge that there’s still so much more that needs to be done.

European MG Day is a key milestone in the mobilisation of the MG community who will continue to advocate for a better life, for each and every person living with this disease.

MG affects up to 123,000 people across Europe – with a significant impact on daily life.^1,2 It can disrupt routines at home, school and/or in the workplace. And this can go on to affect family, social circles, education or career progression, as well as physical and mental wellbeing.² But this doesn’t mean that life can’t still be lived to the fullest.

#AllUnitedForMG

What is European MG Day?

This is a day where we act as a collective to give a voice to MG patients, to raise awareness and improve care. It's a day to inform patients, caregivers, policymakers, and the broader public, to increase visibility of this disease and make sure the right support is available to those who need it – now and in the future. This is also a day to truly understand what it is to be a patient with MG.

It is the cumulative effort of MG patient associations from across Europe, united under a single banner to make this day possible.

This year is particularly special as it is the first ever ‘MG Day’ in Europe.

What is MG?

Myasthenia gravis (MG) is a serious, rare, and chronic neuromuscular autoimmune disease where the body's own defences can cause debilitating and potentially life-threatening muscle weakness.^3,4 Put simply, the body's natural defences are not working the way they’re supposed to.³ It often starts in the face, with first signs including eye muscle weakness that can lead to drooping eyelids and double or blurred vision.^3,4,5 MG also affects muscles involved in talking, chewing, swallowing, and breathing, and can extend to the arms and legs.^3,4,5

Because MG is rare, it can be difficult to recognise and fully understand the disease, its symptoms and the day-to-day impact. This can lead to delays in diagnosis and ineffective treatment.

Get involved with our MG Day activities to help change this. And change lives.

ABBM

Association Belge Contre Les Maladies Neuro – Musculaires Asbl
Jean-Marie Huet
President of ABMM
jmh7033@gmail.com

VISIT THEIR WEBSITE

AIM

Associazione Italiana Miastenia
Romina Givbertoni
Coordinator of AIM
aim@istituto-besta.it

VISIT THEIR WEBSITE

AMES

Associacion Miastenia de España
Raquel Pardo
President AMES
presidencia@miastenia.ong

VISIT THEIR WEBSITE

AMIS

Associations des myasthéniques isolés & Solidaires
Pierre Boulanger
President AMiS
pierre.boulanger@myasthenie.com

VISIT THEIR WEBSITE

MG-RO

Asociatia Nationala Miastenia Gravis Romania
Adriana Harja
President of Romanian Myasthenia Gravis Association
asociatia.miastenia@gmail.com

VISIT THEIR WEBSITE

H-MGA

Hellenic Myasthenia Gravis Association
Dimitris Zaftis
Vice President of H-MGA
mr.enduras@gmail.com

VISIT THEIR WEBSITE

MG Liga

Liga Myastenia Gravis
Lutgarde Allard
Board Member of MG Liga
allard.lutgarde@skynet.be

VISIT THEIR WEBSITE

Groupe Myasthenique AFM telethon

Groupe d'intérêt Myasthenique – AFM telethon
Annie Archer
President du groupe myasthénique de AFM telethon
aarcher@afm-telethon.fr

VISIT THEIR WEBSITE

Face 2 Face Myasthenia

Face 2 Face Myasthenia
Sylwia Luko
President of Face 2 Face Mysathenia
sylwialuko@gmail.com

References

Bubuioc AM, et al. J Med Life. 2021;14(1):7-16.
Szczudlik P, et al. Front Neurol. 2020;11:553626.
Gilhus NE, et al. Nat Rev Dis Primers. 2019;5(1):30.
Stetefeld H, et al. Neurol Res Pract. 2019;1(19):1-6.
Mantegazza R, et al. Ann N Y Acad Sci. 2003;998:413-23

SIGN UP TO HEAR MORE!

Be informed about the All United For MG campaign and our activities in Europe and connect with the wider community

*indicates required field

First Name*

Last Name*

Email Address*

Country*

I am:

audience type A patient A HCP A caregiver or family member of a patient A supporter of the campaign I prefer not to say

Opt ins I am 18 years of age or older*

Opt ins I have read and accept the Privacy Policy*

I authorize argenx BV, Industriepark Zwijnaarde 7, 9052 Zwijnaarde (Ghent), Belgium ("argenx"), its affiliates and companies working with argenx worldwide to use my personal information as provided above (“Information”)

Opt ins to sign me up to stay in contact with All United For MG to receive via email news, updates and activities relating to myasthenia gravis from argenx.

Opt ins to contact me by email to provide me with medical and scientific information, offers, activities and resources regarding myasthenia gravis, to conduct market research or surveys, and to use my information to develop future services and programs.

I understand that I may withdraw my authorization provided above by emailing dpo@argenx.com or following the unsubscribe instructions on the communication. Unless I withdraw this authorization, it will remain effective for 2 years. Copies of this authorization may be obtained by emailing dpo@argenx.com.

The All United For MG website collects anonymous usage data to help us improve the website and your user experience. These usage data are processed in an aggregated anonymous format and do not include any personal identifiers. Further information can be found in our Privacy Policy.

Thank you, again.

We’ll keep you informed of the All United For MG activities across Europe.